accession	classification	samplingFrame	paper	length
AY184220	Sabin2	Sabin 2	Mutations in Sabin 2 strain of poliovirus and stability ofattenuation phenotype 	2637
KX162717	SabinLike	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162716	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162715	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162714	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162713	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162712	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162711	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162710	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162707	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162706	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162705	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162704	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162703	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162702	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162701	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162700	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162699	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162698	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162697	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162696	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162690	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162689	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162688	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162687	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162686	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162685	SabinLike	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KX162678	cVDPV	AFP	High-Throughput Next Generation Sequencing of Polioviruses	2637
KJ170575	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170574	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170573	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170572	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170571	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170570	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170569	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170568	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170567	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170566	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170565	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170564	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170563	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170562	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170561	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170560	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170559	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170558	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170557	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170556	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170555	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170554	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170553	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170552	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170551	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170550	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170549	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170548	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170547	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170546	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170545	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170544	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170543	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170542	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170541	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170540	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170539	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170538	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170537	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170536	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170535	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170534	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KJ170533	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	2637
KU598891	VDPV	AFP	A cluster of paralytic poliomyelitis cases due to transmission ofslightly diverged Sabin-2 vaccine virus 	2637
KU598890	VDPV	healthy	A cluster of paralytic poliomyelitis cases due to transmission ofslightly diverged Sabin-2 vaccine virus 	2637
KU598888	VDPV	AFP	A cluster of paralytic poliomyelitis cases due to transmission ofslightly diverged Sabin-2 vaccine virus 	2637
KU598887	VDPV	AFP	A cluster of paralytic poliomyelitis cases due to transmission ofslightly diverged Sabin-2 vaccine virus 	2637
KU598886	VDPV	AFP	A cluster of paralytic poliomyelitis cases due to transmission ofslightly diverged Sabin-2 vaccine virus 	2637
KU598885	VDPV	AFP	A cluster of paralytic poliomyelitis cases due to transmission ofslightly diverged Sabin-2 vaccine virus 	2637
KU598884	VDPV	AFP	A cluster of paralytic poliomyelitis cases due to transmission ofslightly diverged Sabin-2 vaccine virus 	2637
KU598883	VDPV	AFP	A cluster of paralytic poliomyelitis cases due to transmission ofslightly diverged Sabin-2 vaccine virus 	2637
KU372652	VDPV	environmental	Molecular and Phenotypic Characterization of a Highly Evolved Type 2 Vaccine-Derived Poliovirus Isolated from Seawater in Brazil, 2014	2637
KM433732	SabinLike	AFP-CSF	Complete genome sequence analysis of a poliovirus type 2 strainisolated in Yunnan, China, in 2013 	2637
KR259357	VDPV	AFP	Vaccine-Derived Polioviruses Not Detected by Global SurveillanceScreening Assay 	2637
KR259356	VDPV	AFP	Vaccine-Derived Polioviruses Not Detected by Global SurveillanceScreening Assay 	2637
KP196613	VDPV	AFP	The Genetic Character Analysis of Type 2 Vaccine-derived Poliovirusin Shanxi Province in 2014 	2637
KJ419277	cVDPV	healthy	Limited and localized outbreak of newly emergent type 2vaccine-derived poliovirus in sichuan, china 	2637
KJ419276	cVDPV	AFP	Limited and localized outbreak of newly emergent type 2vaccine-derived poliovirus in sichuan, china 	2637
KJ419275	cVDPV	AFP	Limited and localized outbreak of newly emergent type 2vaccine-derived poliovirus in sichuan, china 	2637
KJ419274	cVDPV	AFP	Limited and localized outbreak of newly emergent type 2vaccine-derived poliovirus in sichuan, china 	2637
KJ419273	cVDPV	AFP	Limited and localized outbreak of newly emergent type 2vaccine-derived poliovirus in sichuan, china 	2637
KF656732	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	2637
KC784367	VDPV	environmental	Highly Divergent Types 2 and 3 Vaccine-Derived PoliovirusesIsolated from Sewage in Tallinn, Estonia 	2637
HF913428	VDPV	healthy	Reemergence of Recombinant Vaccine-derived Polioviruses in HealthyChildren, Madagascar 	2637
HF913427	VDPV	healthy	Reemergence of Recombinant Vaccine-derived Polioviruses in HealthyChildren, Madagascar 	2637
HF913426	VDPV	healthy	Reemergence of Recombinant Vaccine-derived Polioviruses in HealthyChildren, Madagascar 	2637
JX275380	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275352	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275266	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275238	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275184	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275162	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275147	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275140	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275085	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275071	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275032	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275015	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275008	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274999	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274995	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274993	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274991	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274987	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274985	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274984	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274983	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274982	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274981	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274980	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
AY278552	VDPV	healthy	Retrospective analysis of a local cessation of vaccination againstpoliomyelitis: a possible scenario for the future 	2637
AY278551	VDPV	AFP	Retrospective analysis of a local cessation of vaccination againstpoliomyelitis: a possible scenario for the future 	2637
AY278550	VDPV	healthy	Retrospective analysis of a local cessation of vaccination againstpoliomyelitis: a possible scenario for the future 	2637
AY278549	VDPV	healthy	Retrospective analysis of a local cessation of vaccination againstpoliomyelitis: a possible scenario for the future 	2637
HM107835	SabinLike	AFP	Type 2 vaccine-derived poliovirus from patients with acute flaccidparalysis in china: current immunization strategy effectively prevented its sustained transmission 	2637
HM107834	VDPV	AFP	Type 2 vaccine-derived poliovirus from patients with acute flaccidparalysis in china: current immunization strategy effectively prevented its sustained transmission 	2637
HM107833	VDPV	AFP	Type 2 vaccine-derived poliovirus from patients with acute flaccidparalysis in china: current immunization strategy effectively prevented its sustained transmission 	2637
HM107832	VDPV	AFP	Type 2 vaccine-derived poliovirus from patients with acute flaccidparalysis in china: current immunization strategy effectively prevented its sustained transmission 	2637
AY177685	iVDPV	AFP	Nucleotide variation in Sabin type 2 poliovirus from animmunodeficient patient with poliomyelitis 	2637
FJ460225	VDPV	healthy	Comparison of poliovirus recombinants: accumulation of pointmutations provides further advantages 	2637
FJ460224	VDPV	healthy	Comparison of poliovirus recombinants: accumulation of pointmutations provides further advantages 	2637
FJ460223	VDPV	healthy	Comparison of poliovirus recombinants: accumulation of pointmutations provides further advantages 	2637
FJ517649	VDPV	AFP	Evolution of the Sabin vaccine into pathogenic derivatives withoutappreciable changes in antigenic properties: need for improvement of current poliovirus surveillance 	2637
FJ517648	VDPV	AFP	Evolution of the Sabin vaccine into pathogenic derivatives withoutappreciable changes in antigenic properties: need for improvement of current poliovirus surveillance 	2637
EU566950	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566949	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566948	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566947	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566946	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566945	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566944	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566943	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566942	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566941	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566940	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566939	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566938	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566937	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566936	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566935	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
EU566934	iVDPV	AFP	Paralysis Associated and Contact Spreading of an ImportedRecombinant Vaccine Derived Poliovirus in Spain 	2637
DQ890388	VDPV	AFP	Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV)from a Nigerian child 	2637
DQ890387	VDPV	AFP	Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV)from a Nigerian child 	2637
DQ890386	VDPV	AFP	Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV)from a Nigerian child 	2637
DQ890385	VDPV	AFP	Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV)from a Nigerian child 	2637
AF448783	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	2637
AF448782	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	2637
FJ898290	VDPV	AFP	A Sabin 2-related poliovirus recombinant contains a homologous sequence of human enterovirus species C in the viral polymerasecoding region 	2637
AY948201	VDPV	AFP	Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a childwith acute flaccid paralysis 	2637
DQ205099	engineered	engineered	Modulation of Poliovirus Replicative Fitness in HeLa Cells byDeoptimization of Synonymous Codon Usage in the Capsid Region	2637
AY238473	MEF1	MEF1	Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method forpredicting vaccine efficacy 	2637
AM084225	cVDPV	AFP	Co-circulation and evolution of polioviruses and species Centeroviruses in a district of Madagascar 	2637
AM084224	cVDPV	AFP	Co-circulation and evolution of polioviruses and species Centeroviruses in a district of Madagascar 	2637
AM084223	cVDPV	AFP	Co-circulation and evolution of polioviruses and species Centeroviruses in a district of Madagascar 	2637
AM884185	cVDPV	healthy	Co-circulation and evolution of polioviruses and species Centeroviruses in a district of Madagascar 	2637
AM884184	cVDPV	healthy	Co-circulation and evolution of polioviruses and species Centeroviruses in a district of Madagascar 	2637
AM056050	VDPV	environmental	Neurovirulent vaccine-derived polioviruses in sewage from highlyimmune populations 	2637
AM056049	VDPV	environmental	Neurovirulent vaccine-derived polioviruses in sewage from highlyimmune populations 	2637
AM040039	VDPV	environmental	Neurovirulent vaccine-derived polioviruses in sewage from highlyimmune populations 	2637
AM040038	VDPV	environmental	Neurovirulent vaccine-derived polioviruses in sewage from highlyimmune populations 	2637
AM040037	VDPV	environmental	Neurovirulent vaccine-derived polioviruses in sewage from highlyimmune populations 	2637
AM040036	VDPV	environmental	Neurovirulent vaccine-derived polioviruses in sewage from highlyimmune populations 	2637
AM040035	VDPV	environmental	Neurovirulent vaccine-derived polioviruses in sewage from highlyimmune populations 	2637
AJ544513	iVDPV	healthy	Characterisation of a type 2 poliovirus strain from long-termexcretor with CVID immunodeficiency 	2637
AM292221	VDPV	environmental	Neurovirulent vaccine-derived polioviruses in sewage from highlyimmune populations 	2637
AM292220	VDPV	environmental	Neurovirulent vaccine-derived polioviruses in sewage from highlyimmune populations 	2637
AM292219	VDPV	environmental	Neurovirulent vaccine-derived polioviruses in sewage from highlyimmune populations 	2637
AM158276	VDPV	environmental	Neurovirulent vaccine-derived polioviruses in sewage from highlyimmune populations 	2637
CS406483	engineered	engineered	Modulation of replicative fitness by using less frequently usedsynonymous codons 	2637
CS406482	engineered	engineered	Modulation of replicative fitness by using less frequently usedsynonymous codons 	2637
M12197	Lansing	Lansing	Mapping of sequences required for mouse neurovirulence ofpoliovirus type 2 Lansing 	2637
KF322158	cVDPV	AFP	Evolution and Circulation of Type-2 Vaccine-Derived Polioviruses inNad Ali District of Southern Afghanistan during June 2009-February 2011 	2637
KF322157	cVDPV	AFP	Evolution and Circulation of Type-2 Vaccine-Derived Polioviruses inNad Ali District of Southern Afghanistan during June 2009-February 2011 	2637
KF322156	cVDPV	AFP	Evolution and Circulation of Type-2 Vaccine-Derived Polioviruses inNad Ali District of Southern Afghanistan during June 2009-February 2011 	2637
KF322155	cVDPV	AFP	Evolution and Circulation of Type-2 Vaccine-Derived Polioviruses inNad Ali District of Southern Afghanistan during June 2009-February 2011 	2637
KF322154	cVDPV	AFP	Evolution and Circulation of Type-2 Vaccine-Derived Polioviruses inNad Ali District of Southern Afghanistan during June 2009-February 2011 	2637
KF322153	cVDPV	AFP	Evolution and Circulation of Type-2 Vaccine-Derived Polioviruses inNad Ali District of Southern Afghanistan during June 2009-February 2011 	2637
KF322152	cVDPV	AFP	Evolution and Circulation of Type-2 Vaccine-Derived Polioviruses inNad Ali District of Southern Afghanistan during June 2009-February 2011 	2637
CS406436	engineered	engineered	Modulation of replicative fitness by using less frequently usedsynonymous codons 	2637
CS406433	engineered	engineered	Modulation of replicative fitness by using less frequently usedsynonymous codons 	2637
HQ703554	VDPV	environmental	Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes againstHighly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates 	2637
HQ703551	VDPV	environmental	Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes againstHighly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates 	2637
GU390706	cVDPV	AFP	Brief Report: Neuroinvasive Immunodeficiency-Associated Vaccine-Derived Poliomyelitis Thirteen Years after Infection -Minnesota, 2008 	2637
GU390705	cVDPV	AFP	Brief Report: Neuroinvasive Immunodeficiency-Associated Vaccine-Derived Poliomyelitis Thirteen Years after Infection -Minnesota, 2008 	2637
GU390704	iVDPV	AFP	Brief Report: Neuroinvasive Immunodeficiency-Associated Vaccine-Derived Poliomyelitis Thirteen Years after Infection -Minnesota, 2008 	2637
KR817066	wild	AFP	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2637
KR817065	wild	AFP	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2637
KR817064	wild	AFP	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2637
KR817063	wild	AFP	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2637
KR817062	wild	AFP	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2637
KR817061	wild	AFP	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2637
KR817060	iVDPV	healthy	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2637
KR817059	iVDPV	healthy	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2637
KR817058	iVDPV	healthy	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2637
KR817057	iVDPV	healthy	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2637
KR817056	iVDPV	healthy	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2637
KR817052	iVDPV	healthy	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2637
KR817051	iVDPV	healthy	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2637
KR817050	iVDPV	healthy	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2637
KC784370	VDPV	environmental	Highly Divergent Types 2 and 3 Vaccine-Derived PoliovirusesIsolated from Sewage in Tallinn, Estonia 	2637
KC784369	VDPV	environmental	Highly Divergent Types 2 and 3 Vaccine-Derived PoliovirusesIsolated from Sewage in Tallinn, Estonia 	2637
JX275382	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275381	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275379	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275378	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275377	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275376	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275375	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275374	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275373	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275372	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275371	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275370	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275369	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275368	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275367	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275366	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275365	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275364	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275363	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275362	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275361	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275360	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275359	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275358	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275357	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275356	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275355	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275354	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275353	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275351	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275350	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275349	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275348	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275347	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275346	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275345	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275344	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275343	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275342	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275341	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275340	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275339	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275338	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275337	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275336	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275335	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275334	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275333	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275332	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275331	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275330	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275329	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275328	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275327	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275326	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275325	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275324	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275323	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275322	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275321	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275320	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275319	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275318	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275317	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275316	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275315	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275314	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275313	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275312	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275311	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275310	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275309	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275308	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275307	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275306	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275305	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275304	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275303	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275302	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275301	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275300	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275299	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275298	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275297	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275296	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275295	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275294	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275293	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275292	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275291	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275290	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275289	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275287	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275286	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275285	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275284	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275283	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275282	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275281	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275280	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275279	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275278	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275277	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275276	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275275	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275274	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275273	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275272	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275271	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275270	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275269	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275268	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275267	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275265	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275264	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275263	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275262	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275261	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275260	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275259	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275258	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275257	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275256	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275255	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275254	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275253	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275252	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275251	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275250	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275249	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275248	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275247	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275246	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275245	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275244	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275243	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275242	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275241	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275240	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275239	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275237	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275236	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275235	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275234	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275233	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275232	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275231	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275230	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275229	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275228	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275227	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275226	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275225	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275224	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275223	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275222	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275221	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275220	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275219	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275218	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275217	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275216	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275215	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275214	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275213	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275212	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275211	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275210	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275209	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275208	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275207	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275206	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275205	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275204	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275203	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275202	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275201	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275200	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275199	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275198	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275197	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275196	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275195	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275194	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275193	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275192	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275191	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275190	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275189	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275188	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275187	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275186	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275185	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275183	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275182	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275181	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275180	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275179	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275178	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275177	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275176	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275175	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275174	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275173	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275172	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275171	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275170	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275169	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275168	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275167	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275166	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275165	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275164	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275163	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275161	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275160	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275159	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275158	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275157	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275156	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275155	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275154	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275153	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275152	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275151	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275150	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275149	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275148	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275146	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275145	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275144	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275143	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275142	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275141	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275139	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275138	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275137	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275136	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275135	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275134	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275133	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275132	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275131	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275130	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275129	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275128	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275127	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275126	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275125	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275124	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275123	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275122	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275121	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275120	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275119	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275118	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275117	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275116	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275115	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275114	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275113	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275112	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275111	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275110	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275109	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275108	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275107	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275105	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275104	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275103	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275102	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275101	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275100	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275099	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275098	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275097	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275096	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275095	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275094	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275093	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275092	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275091	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275090	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275089	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275088	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275087	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275086	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275084	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275083	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275082	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275081	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275080	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275079	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275078	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275077	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275076	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275075	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275074	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275072	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275069	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275068	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275067	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275066	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275065	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275064	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275063	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275062	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275061	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275060	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275059	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275058	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275057	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275056	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275055	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275054	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275053	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275052	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275051	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275050	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275049	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275048	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275047	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275046	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275045	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275044	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275043	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275042	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275041	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275040	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275039	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275038	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275037	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275036	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275035	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275034	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275033	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275031	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275030	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275029	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275028	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275027	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275026	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275025	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275024	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275023	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275022	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275021	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275020	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275019	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275018	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275017	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275016	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275014	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275013	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275012	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275011	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275010	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275009	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275007	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275006	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275005	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275004	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275003	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275002	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275001	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX275000	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274998	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274997	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274996	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274994	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274992	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274990	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274989	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274988	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JX274986	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2637
JN105292	v073-antiviral	engineered	Characterization of poliovirus variants selected for resistance tothe antiviral compound v-073 	2637
JN105291	v073-antiviral	engineered	Characterization of poliovirus variants selected for resistance tothe antiviral compound v-073 	2637
HM537005	SabinLike	AFP	Determination of antigenic properties of vaccine derived poliovirusstrains 	2637
HM537004	SabinLike	AFP	Determination of antigenic properties of vaccine derived poliovirusstrains 	2637
HM537003	SabinLike	AFP	Determination of antigenic properties of vaccine derived poliovirusstrains 	2637
HQ703555	VDPV	environmental	Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes againstHighly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates 	2636
HQ703553	VDPV	environmental	Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes againstHighly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates 	2636
HQ703552	VDPV	environmental	Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes againstHighly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates 	2636
HM537006	SabinLike	AFP	Determination of antigenic properties of vaccine derived poliovirusstrains 	2636
KU598889	VDPV	healthy	A cluster of paralytic poliomyelitis cases due to transmission ofslightly diverged Sabin-2 vaccine virus 	2634
KC784368	VDPV	environmental	Highly Divergent Types 2 and 3 Vaccine-Derived PoliovirusesIsolated from Sewage in Tallinn, Estonia 	2634
GU390707	iVDPV	AFP	Brief Report: Neuroinvasive Immunodeficiency-Associated Vaccine-Derived Poliomyelitis Thirteen Years after Infection -Minnesota, 2008 	2634
KR817055	iVDPV	healthy	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2634
KR817054	iVDPV	healthy	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2634
KR817053	iVDPV	healthy	Twenty-eight years of poliovirus replication in an immunodeficientindividual: impact on the global polio eradication initiative 	2634
JX275288	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2634
JX275106	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2634
JX275073	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2634
JX275070	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in Northern Nigeria 	2634
AY649330	iVDPV	environmental	Spread of vaccine-derived poliovirus from a paralytic case in animmunodeficient child: an insight into the natural evolution of oral polio vaccine 	2430
AY649329	iVDPV	AFP	Spread of vaccine-derived poliovirus from a paralytic case in animmunodeficient child: an insight into the natural evolution of oral polio vaccine 	2430
AY649328	iVDPV	AFP	Spread of vaccine-derived poliovirus from a paralytic case in animmunodeficient child: an insight into the natural evolution of oral polio vaccine 	2430
AY649327	iVDPV	AFP	Spread of vaccine-derived poliovirus from a paralytic case in animmunodeficient child: an insight into the natural evolution of oral polio vaccine 	2430
AM158275	VDPV	environmental	Neurovirulent vaccine-derived polioviruses in sewage from highlyimmune populations 	1504
DQ264376	SabinLike	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264375	SabinLike	environmental	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264374	SabinLike	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264373	SabinLike	AFP	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264372	SabinLike	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264371	SabinLike	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264370	SabinLike	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264369	VDPV	environmental	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264368	SabinLike	environmental	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264367	SabinLike	environmental	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264366	SabinLike	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264365	SabinLike	environmental	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264364	VDPV	AFP	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264363	VDPV	AFP	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264362	SabinLike	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264361	SabinLike	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264360	SabinLike	environmental	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
DQ264359	SabinLike	AFP	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	1173
AB829580	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	975
AB829560	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	975
AB921175	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	972
AB829555	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	963
AJ288078	wild	environmental	A highly evolved derivative of the type 2 oral poliovaccine strainisolated from sewage in Israel: molecular and antigenic characterization 	958
AB921179	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	954
AB921177	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	948
AB921176	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	948
AB829582	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	948
AB829581	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	948
AB829576	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	948
AB829571	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	948
AB829567	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	948
AB829566	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	948
AB829557	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	948
AB980989	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	945
AB980988	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	945
AB980987	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	945
AB980986	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	945
AB980985	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	945
AB829564	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	945
AB829562	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	945
AB829558	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	945
AB921178	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	942
AB829577	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	942
AB829574	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	942
AB829568	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	942
AB829559	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	942
AB829556	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	939
AB921180	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	933
HQ694493	SabinLike	healthy	Virological surveillance of enteroviruses from healthy children inthe border areas with Myanma, Yunnan Province, China, 2009 	933
AB829578	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	930
AB829579	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	927
AB829565	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	924
AB829583	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	921
AB829575	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	912
AB829572	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	912
AB829569	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	909
AB829570	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	906
AJ288068	VDPV	environmental	A highly evolved derivative of the type 2 oral poliovaccine strainisolated from sewage in Israel: molecular and antigenic characterization 	903
AB467771	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467770	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467769	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467768	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467766	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467765	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467764	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467763	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467761	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467760	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467759	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467758	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467757	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467756	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467755	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467754	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467753	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467752	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467751	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467750	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467749	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467748	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467747	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467746	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467745	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467744	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467743	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467742	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467741	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467740	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467739	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467738	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467737	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467736	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467735	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467734	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467733	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467732	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467731	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467730	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467729	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467728	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467726	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467725	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467814	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467813	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467812	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467811	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467808	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467807	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467806	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467805	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467804	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467803	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467802	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467801	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467799	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467798	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467797	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467796	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467795	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467794	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467792	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467791	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467790	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467789	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467787	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467786	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467785	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467784	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467783	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467782	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467781	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467780	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467779	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467778	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467777	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467776	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467775	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467774	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
AB467773	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	903
LC143304	SabinLike	healthy	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143303	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143302	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143301	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143300	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143299	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143298	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143297	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143296	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143295	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143294	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143293	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143292	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143291	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143290	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143289	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143288	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143287	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143286	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143285	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143284	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143283	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143282	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143281	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143280	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143279	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143278	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143277	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143276	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143275	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143274	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143273	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143272	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143271	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143270	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143269	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143268	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143267	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143266	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143265	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143264	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143263	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143262	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
LC143261	SabinLike	environmental	Surveillance of human enteric viruses isolated from raw sewage andclinical cases in Toyama Prefecture, Japan, from 2006 to 2013 	903
AB629952	SabinLike	environmental	Development of real-time PCR to detect oral vaccine-like poliovirusand its application to environmental surveillance 	903
AB629951	SabinLike	environmental	Development of real-time PCR to detect oral vaccine-like poliovirusand its application to environmental surveillance 	903
KY884692	SabinLike	environmental	Polio and measles down the drain: Environmental EnterovirusSurveillance in the Netherlands, 2005-2015 	903
KU878958	iVDPV	AFP	Neutralization capacity of highly divergent type 2 vaccine-derivedpolioviruses from immunodficient patients 	903
KU878957	iVDPV	AFP	Neutralization capacity of highly divergent type 2 vaccine-derivedpolioviruses from immunodficient patients 	903
KU878956	iVDPV	AFP	Neutralization capacity of highly divergent type 2 vaccine-derivedpolioviruses from immunodficient patients 	903
KU878955	iVDPV	AFP	Neutralization capacity of highly divergent type 2 vaccine-derivedpolioviruses from immunodficient patients 	903
KU878954	iVDPV	AFP	Neutralization capacity of highly divergent type 2 vaccine-derivedpolioviruses from immunodficient patients 	903
AY082677	MEF1	MEF1	Poliovirus type 2 reference sequences	903
AY082678	Lederle2	Lederle2	Poliovirus type 2 reference sequences	903
AY082676	W-2	W-2	Poliovirus type 2 reference sequences	903
JF313098	wild	AFP	Poliovirus reference strains	903
JF313097	VDPV	AFP	Poliovirus reference strains	903
DQ264305	VDPV	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264304	SabinLike	environmental	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264303	SabinLike	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264302	SabinLike	AFP	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264301	VDPV	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264300	SabinLike	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264299	SabinLike	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264298	SabinLike	environmental	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264297	SabinLike	environmental	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264296	SabinLike	environmental	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264295	SabinLike	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264294	SabinLike	environmental	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264293	VDPV	AFP	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264292	VDPV	AFP	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264291	SabinLike	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264290	VDPV	healthy	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264289	SabinLike	environmental	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
DQ264288	SabinLike	AFP	Antigenic evolution of vaccine-derived polioviruses: changes inindividual epitopes and relative stability of the overall immunological properties 	903
HM134120	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134119	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134118	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134117	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134116	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134115	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134114	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134113	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134112	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134111	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134110	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134109	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134108	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134107	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134106	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134105	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134104	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134103	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134102	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134101	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134100	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134099	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134098	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134097	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134096	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HM134095	cVDPV	AFP	Vaccine Derived Polioviruses (VDPV) threatening eradication ofpolio in the Democratic Republic of Congo (DRC) 	903
HQ286320	wild	AFP	The Picornaviruses Chapter 26: The poliovirus eradicationinitiative 	903
GU256637	SabinLike	AFP	Growth kinetic analysis of bi-recombinant poliovirus vaccinestrains 	903
FJ868310	SabinLike	AFP	Identification of 20 common human enterovirus serotypes by use of areverse transcription-PCR-based reverse line blot hybridization assay 	903
FJ609772	SabinLike	unknown	Study of antigenic evolution of vaccine poliovirus strains and determination of their immunological properties in Greek population	903
AY308802	USA53	unknown	Polio Type 2 Reference Strain	903
AF551841	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551840	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551839	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551838	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551837	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551836	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551835	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551834	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551833	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551832	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551831	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551830	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551829	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551828	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551827	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551826	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551825	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551824	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551823	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551822	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551821	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551820	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551819	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551818	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551817	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551816	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551815	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551814	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551813	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551812	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551811	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551810	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551809	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551808	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551807	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551806	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551805	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551804	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551803	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551802	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551799	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551798	wild	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551797	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551796	cVDPV	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
AF551795	wild	AFP	Circulation of endemic type 2 vaccine-derived poliovirus in Egyptfrom 1983 to 1993 	903
EU004574	cVDPV	healthy	Molecular analysis and implications of neurovirulent circulating vaccine-derived poliovirus in Jamaica. A case report and review ofliterature 	903
EF420871	VDPV	AFP	Identification and characterization of type 2 and type 3 vaccine derived polioviruses isolated during an outbreak of poliomyelitisin Madagascar in 2005 	903
EF420870	VDPV	AFP	Identification and characterization of type 2 and type 3 vaccine derived polioviruses isolated during an outbreak of poliomyelitisin Madagascar in 2005 	903
EF420869	VDPV	AFP	Identification and characterization of type 2 and type 3 vaccine derived polioviruses isolated during an outbreak of poliomyelitisin Madagascar in 2005 	903
EF420868	VDPV	AFP	Identification and characterization of type 2 and type 3 vaccine derived polioviruses isolated during an outbreak of poliomyelitisin Madagascar in 2005 	903
EF420867	VDPV	AFP	Identification and characterization of type 2 and type 3 vaccine derived polioviruses isolated during an outbreak of poliomyelitisin Madagascar in 2005 	903
EF420866	VDPV	AFP	Identification and characterization of type 2 and type 3 vaccine derived polioviruses isolated during an outbreak of poliomyelitisin Madagascar in 2005 	903
EF420865	VDPV	AFP	Identification and characterization of type 2 and type 3 vaccine derived polioviruses isolated during an outbreak of poliomyelitisin Madagascar in 2005 	903
EF420864	VDPV	AFP	Identification and characterization of type 2 and type 3 vaccine derived polioviruses isolated during an outbreak of poliomyelitisin Madagascar in 2005 	903
KJ170426	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	903
KJ170425	SabinLike	AFP	Sabin Vaccine Reversion in the Field: a Comprehensive Analysis ofSabin-Like Poliovirus Isolates in Nigeria 	903
KR709242	iVDPV	healthy	Two Cases of Vaccine-Derived Poliovirus Infection in an OncologyWard 	903
KR709241	iVDPV	healthy	Two Cases of Vaccine-Derived Poliovirus Infection in an OncologyWard 	903
LC120946	SabinLike	healthy	Detection of enteroviruses from healthy children, Yunnan province,China, 2014-2015 	903
AB861640	SabinLike	healthy	Molecular typing of enteroviruses from healthy Children, YunnanProvince, China, 2013 	903
KU198435	VDPV	environmental	Molecular and Phenotypic Characterization of a Highly Evolved Type2 Vaccine-Derived Poliovirus Isolated from Sewage in Brazil, 2014 	903
KF701306	VDPV	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701305	VDPV	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701304	VDPV	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701303	VDPV	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701298	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701297	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701296	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701295	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701294	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701293	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701292	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701291	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701290	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701289	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701288	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701287	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701286	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701285	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701284	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701283	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701282	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701281	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701280	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701279	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701278	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701277	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701276	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701275	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701274	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701273	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701272	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701271	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701270	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701269	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701268	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701267	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701266	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701265	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701264	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701263	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701262	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701261	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701260	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701259	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701258	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701257	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701256	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701255	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701254	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701253	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701252	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701251	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701250	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701249	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701248	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701247	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701246	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701245	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701244	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701243	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701242	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701241	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701240	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701239	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701238	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701237	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701236	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701235	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701234	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KF701233	SabinLike	environmental	Detection of vaccine-derived polioviruses in Mexico usingenvironmental surveillance 	903
KP143072	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143071	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143070	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143069	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143068	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143067	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143066	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143065	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143064	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143063	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143062	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143061	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143060	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143059	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143058	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143057	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143056	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143055	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143054	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143053	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143052	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143051	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143050	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143049	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143048	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143047	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143046	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
KP143045	cVDPV	AFP	Circulating vaccine-derived polioviruses in the Extreme Northregion of Cameroon 	903
AB629950	VDPV	healthy	Development of real-time PCR to detect oral vaccine-like poliovirusand its application to environmental surveillance 	903
KJ852635	SabinLike	environmental	Sporadic Isolation of Sabin-Like Polioviruses and High-Level Detection of Non-Polio Enteroviruses during Sewage Surveillance in Seven Italian Cities, after Several Years of Inactivated PoliovirusVaccination 	903
KJ852634	SabinLike	environmental	Sporadic Isolation of Sabin-Like Polioviruses and High-Level Detection of Non-Polio Enteroviruses during Sewage Surveillance in Seven Italian Cities, after Several Years of Inactivated PoliovirusVaccination 	903
KF666633	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666632	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666631	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666630	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666629	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666628	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666627	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666626	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666625	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666624	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666623	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666622	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666621	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666620	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666619	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666618	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666617	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666616	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666615	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666614	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666613	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666612	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666611	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666610	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666609	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666608	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666607	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666606	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666605	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666604	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666603	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666602	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666601	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666600	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666599	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666598	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666597	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666596	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666595	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666594	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666593	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666592	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666591	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666590	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666589	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666588	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666587	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666586	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666585	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666584	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666583	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666582	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666581	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666580	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666579	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666578	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666577	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666576	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666575	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666574	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666573	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666572	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666571	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666570	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666569	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KF666568	VDPV	environmental	Isolation and Characterization of a Type 2 Vaccine-DerivedPoliovirus from Environmental Surveillance in China, 2012 	903
KC784371	VDPV	environmental	Highly Divergent Types 2 and 3 Vaccine-Derived PoliovirusesIsolated from Sewage in Tallinn, Estonia 	903
JX424836	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JX424835	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JX424834	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JX424833	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JX424832	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JX424831	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JX424830	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JX424829	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JX424828	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JX424827	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JX424826	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JX424825	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JX424824	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691413	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691412	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691411	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691410	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691409	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691408	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691407	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691406	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691405	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691404	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691403	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691402	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691401	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691400	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691399	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691398	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691397	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691396	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691395	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691394	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691393	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691392	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691391	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691390	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691389	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691388	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691387	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691386	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691385	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691384	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691383	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691382	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691381	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691380	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691379	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691378	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691377	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691376	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691375	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691374	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691373	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691372	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691371	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691370	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691369	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691368	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691367	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691366	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691365	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691364	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691363	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691362	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691361	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691360	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691359	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691358	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JQ691357	cVDPV	AFP	Emergence of Vaccine-derived Polioviruses, Democratic Republic ofCongo, 2004-2011 	903
JX913647	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913646	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913645	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913644	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913643	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913642	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913641	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913640	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913639	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913638	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913637	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913636	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913635	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913634	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913633	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913632	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913631	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913630	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913629	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913628	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913627	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913626	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913625	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913624	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913623	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913622	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913621	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913620	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913619	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913618	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913617	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913616	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913615	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913614	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913613	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913612	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913611	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913610	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913609	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913608	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913607	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913606	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913605	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913604	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913603	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913602	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913601	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913600	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913599	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913598	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913597	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913596	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913595	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913594	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913593	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913592	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913591	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913590	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913589	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913588	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913587	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913586	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913585	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913584	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913583	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913582	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913581	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913580	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913579	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913578	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913577	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913576	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913575	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913574	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913573	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913572	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913571	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913570	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913569	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913568	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913567	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913566	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913565	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913564	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913563	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913562	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913561	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913560	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913559	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913558	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913557	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913556	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913555	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913554	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913553	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913552	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913551	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913550	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913549	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913548	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913547	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913546	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913545	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913544	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913543	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913542	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
JX913541	VDPV	environmental	Characteristics of an Environmentally Monitored Prolonged Type 2Vaccine Derived Poliovirus Shedding Episode that Stopped withoutIntervention 	903
FR715545	SabinLike	healthy	The frequency and biodiversity of poliovirus and non-polio enterovirus strains isolated from healthy children living in alimited area in Romania 	903
FR715539	SabinLike	healthy	The frequency and biodiversity of poliovirus and non-polio enterovirus strains isolated from healthy children living in alimited area in Romania 	903
JX274979	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274978	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274977	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274976	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274975	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274974	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274973	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274972	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274971	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274970	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274969	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274968	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274967	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274966	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274965	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274964	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274963	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274962	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274961	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274960	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274959	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274958	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274957	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274956	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274955	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274954	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274953	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274952	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274951	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274950	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274949	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274948	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274947	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274946	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274945	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274944	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274943	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274942	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274941	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274940	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274939	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274938	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274937	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274936	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274935	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274934	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274933	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274932	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274931	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274930	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274929	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274928	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274927	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274926	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274925	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274924	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274923	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274922	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274921	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274920	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274919	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274918	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274917	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274916	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274915	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274914	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274913	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274912	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274911	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274910	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274909	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274908	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274907	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274906	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274905	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274904	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274903	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274902	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274901	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274900	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274899	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274898	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274897	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274896	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274895	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274894	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274893	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274892	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274891	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274890	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274889	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274888	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274887	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274886	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274885	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274884	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274883	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274882	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274881	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274880	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274879	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274878	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274877	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274876	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274875	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274874	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274872	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274871	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274870	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274869	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274868	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274866	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274865	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274864	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274863	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274862	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274861	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274860	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274859	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274858	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274857	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274856	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274855	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274854	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274853	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274852	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274851	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274850	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274849	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274848	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274847	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274846	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274845	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274844	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274843	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274842	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274841	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274840	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274839	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274838	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274837	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274836	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274835	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274834	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274833	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274832	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274831	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274830	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274829	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274828	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274827	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274826	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274825	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274824	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274823	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274822	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274821	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274820	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274819	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274818	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274817	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274816	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274815	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274814	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274813	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274812	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274811	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274810	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274809	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274808	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274807	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274806	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274805	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274804	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274803	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274802	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274801	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274800	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274799	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274798	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274797	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274796	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274795	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274794	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274793	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274792	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274791	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274790	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274789	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274788	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274787	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274786	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274785	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274783	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274782	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274781	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274780	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274779	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274778	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274777	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274776	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274775	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274774	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274773	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274770	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274769	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274768	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274767	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274766	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274765	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274764	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274763	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274762	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274761	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274760	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274756	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274755	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274754	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274753	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274752	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274751	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274750	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274749	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274748	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274747	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274746	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274745	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274744	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274743	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274742	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274741	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274740	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274739	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274738	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274737	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274736	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274735	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274734	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274733	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274732	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274731	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274730	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274729	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274728	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274727	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274726	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274725	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274724	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274723	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274721	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274720	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274719	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274718	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274717	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274716	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274715	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274714	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274713	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274712	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274711	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274710	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274709	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274708	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274707	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274706	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274705	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274704	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274703	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274702	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274701	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274700	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274699	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274698	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274697	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274696	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274693	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274691	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274690	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274689	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274687	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274686	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274685	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274684	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274683	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274682	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274681	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
JX274680	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	903
KC136311	SabinLike	AFP	Two Cases of Fatal Respiratory Failure Causing By PoliovirusVaccine Strain 	903
AB739057	SabinLike	healthy	Molecular typing of human enteroviruses from healthy children inYunnan province, 2011 	903
JN688975	SabinLike	AFP	A RT-PCR method for selective amplification and phenotypiccharacterization of all three serotypes of Sabin-related polioviruses from viral mixtures 	903
JN688974	SabinLike	AFP	A RT-PCR method for selective amplification and phenotypiccharacterization of all three serotypes of Sabin-related polioviruses from viral mixtures 	903
JN688973	VDPV	AFP	A RT-PCR method for selective amplification and phenotypiccharacterization of all three serotypes of Sabin-related polioviruses from viral mixtures 	903
JN688972	SabinLike	AFP	A RT-PCR method for selective amplification and phenotypiccharacterization of all three serotypes of Sabin-related polioviruses from viral mixtures 	903
JN688971	SabinLike	AFP	A RT-PCR method for selective amplification and phenotypiccharacterization of all three serotypes of Sabin-related polioviruses from viral mixtures 	903
JQ613995	cVDPV	environmental	Detection of imported wild polioviruses and of vaccine-derivedpolioviruses by environmental surveillance in egypt 	903
JQ613994	cVDPV	environmental	Detection of imported wild polioviruses and of vaccine-derivedpolioviruses by environmental surveillance in egypt 	903
JQ613993	cVDPV	environmental	Detection of imported wild polioviruses and of vaccine-derivedpolioviruses by environmental surveillance in egypt 	903
JQ613992	cVDPV	environmental	Detection of imported wild polioviruses and of vaccine-derivedpolioviruses by environmental surveillance in egypt 	903
JQ613991	cVDPV	environmental	Detection of imported wild polioviruses and of vaccine-derivedpolioviruses by environmental surveillance in egypt 	903
JQ613990	cVDPV	environmental	Detection of imported wild polioviruses and of vaccine-derivedpolioviruses by environmental surveillance in egypt 	903
JQ613989	cVDPV	environmental	Detection of imported wild polioviruses and of vaccine-derivedpolioviruses by environmental surveillance in egypt 	903
JQ613988	cVDPV	environmental	Detection of imported wild polioviruses and of vaccine-derivedpolioviruses by environmental surveillance in egypt 	903
JQ613987	cVDPV	environmental	Detection of imported wild polioviruses and of vaccine-derivedpolioviruses by environmental surveillance in egypt 	903
JQ613986	cVDPV	environmental	Detection of imported wild polioviruses and of vaccine-derivedpolioviruses by environmental surveillance in egypt 	903
JQ613985	cVDPV	environmental	Detection of imported wild polioviruses and of vaccine-derivedpolioviruses by environmental surveillance in egypt 	903
JQ613984	cVDPV	environmental	Detection of imported wild polioviruses and of vaccine-derivedpolioviruses by environmental surveillance in egypt 	903
FJ609776	SabinLike	unknown	Study of antigenic evolution of vaccine poliovirus strains and determination of their immunological properties in Greek population	903
FJ609774	SabinLike	unknown	Study of antigenic evolution of vaccine poliovirus strains and determination of their immunological properties in Greek population	903
FJ609773	SabinLike	unknown	Study of antigenic evolution of vaccine poliovirus strains and determination of their immunological properties in Greek population	903
FJ609771	SabinLike	unknown	Study of antigenic evolution of vaccine poliovirus strains and determination of their immunological properties in Greek population	903
FJ609766	SabinLike	unknown	Study of antigenic evolution of vaccine poliovirus strains and determination of their immunological properties in Greek population	903
FJ609765	SabinLike	unknown	Study of antigenic evolution of vaccine poliovirus strains and determination of their immunological properties in Greek population	903
FJ609764	SabinLike	unknown	Study of antigenic evolution of vaccine poliovirus strains and determination of their immunological properties in Greek population	903
FJ436998	VDPV	environmental	Environmental Poliovirus Surveillance in Switzerland 2006-2008	903
FJ436997	VDPV	environmental	Environmental Poliovirus Surveillance in Switzerland 2006-2008	903
FJ436995	VDPV	environmental	Environmental Poliovirus Surveillance in Switzerland 2006-2008	903
EU598479	SabinLike	unknown	Determination of the role of mutations and recombination in growthrates of Poliovirus vaccine strains 	903
EU598478	SabinLike	unknown	Determination of the role of mutations and recombination in growthrates of Poliovirus vaccine strains 	903
EF490681	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
EF490677	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
EF490676	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
EF490675	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
EF490674	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
EF490673	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
EF490672	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
EF490671	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
EF490670	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
DQ787796	SabinLike	healthy	Use of mutational pattern in 5'-NCR and VP1 regions of poliovirusesfor molecular diagnosis 	903
DQ787795	SabinLike	healthy	Use of mutational pattern in 5'-NCR and VP1 regions of poliovirusesfor molecular diagnosis 	903
DQ787794	SabinLike	AFP	Use of mutational pattern in 5'-NCR and VP1 regions of poliovirusesfor molecular diagnosis 	903
DQ787793	SabinLike	healthy	Use of mutational pattern in 5'-NCR and VP1 regions of poliovirusesfor molecular diagnosis 	903
DQ787792	SabinLike	AFP	Use of mutational pattern in 5'-NCR and VP1 regions of poliovirusesfor molecular diagnosis 	903
DQ787791	SabinLike	healthy	Use of mutational pattern in 5'-NCR and VP1 regions of poliovirusesfor molecular diagnosis 	903
DQ787790	SabinLike	AFP	Use of mutational pattern in 5'-NCR and VP1 regions of poliovirusesfor molecular diagnosis 	903
DQ787789	SabinLike	healthy	Use of mutational pattern in 5'-NCR and VP1 regions of poliovirusesfor molecular diagnosis 	903
DQ787788	SabinLike	healthy	Use of mutational pattern in 5'-NCR and VP1 regions of poliovirusesfor molecular diagnosis 	903
DQ787787	SabinLike	healthy	Use of mutational pattern in 5'-NCR and VP1 regions of poliovirusesfor molecular diagnosis 	903
DQ787786	SabinLike	healthy	Use of mutational pattern in 5'-NCR and VP1 regions of poliovirusesfor molecular diagnosis 	903
DQ841140	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
DQ841139	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
DQ841138	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
DQ841137	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
DQ841136	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
DQ841135	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
DQ841133	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
DQ841132	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
DQ841131	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
DQ841130	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
DQ841129	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
DQ841128	SabinLike	environmental	Isolation of sabin-like polioviruses from wastewater in a countryusing inactivated polio vaccine 	903
AY945795	SabinLike	AFP	Detection of unusual mutation within the VP1 region of differentre-isolates of poliovirus Sabin vaccine 	903
AY945794	SabinLike	AFP	Detection of unusual mutation within the VP1 region of differentre-isolates of poliovirus Sabin vaccine 	903
AY945793	SabinLike	AFP	Detection of unusual mutation within the VP1 region of differentre-isolates of poliovirus Sabin vaccine 	903
AY945792	SabinLike	AFP	Detection of unusual mutation within the VP1 region of differentre-isolates of poliovirus Sabin vaccine 	903
AY945791	SabinLike	AFP	Detection of unusual mutation within the VP1 region of differentre-isolates of poliovirus Sabin vaccine 	903
AM774330	cVDPV	healthy	Co-circulation and evolution of polioviruses and species Centeroviruses in a district of Madagascar 	903
AM774329	cVDPV	healthy	Co-circulation and evolution of polioviruses and species Centeroviruses in a district of Madagascar 	903
AJ288067	VDPV	environmental	A highly evolved derivative of the type 2 oral poliovaccine strainisolated from sewage in Israel: molecular and antigenic characterization 	903
AJ288066	VDPV	environmental	A highly evolved derivative of the type 2 oral poliovaccine strainisolated from sewage in Israel: molecular and antigenic characterization 	903
AJ288065	VDPV	environmental	A highly evolved derivative of the type 2 oral poliovaccine strainisolated from sewage in Israel: molecular and antigenic characterization 	903
AJ288064	VDPV	environmental	A highly evolved derivative of the type 2 oral poliovaccine strainisolated from sewage in Israel: molecular and antigenic characterization 	903
AJ288063	VDPV	environmental	A highly evolved derivative of the type 2 oral poliovaccine strainisolated from sewage in Israel: molecular and antigenic characterization 	903
AB976096	SabinLike	environmental	Molecular typing of enteroviruses isolated from sewage samples,Yunnan province, China, 2013 	903
AB976095	SabinLike	environmental	Molecular typing of enteroviruses isolated from sewage samples,Yunnan province, China, 2013 	903
AB813053	SabinLike	unknownStool	Molecular typing of enteroviruses in Yuxi city, Yunnan province,China, 2011(part 2) 	903
AB829561	SabinLike	environmental	Environmental surveillance of poliovirus in sewage water around theintroduction period for inactivated polio vaccine in Japan 	900
AB467767	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	900
AB467800	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	900
AB467793	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	900
AB467788	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	900
AB467762	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	897
AB467772	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	897
JX274772	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	897
JX274771	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	897
JX274759	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	892
JX274867	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	887
JX274758	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	885
JX274722	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	884
JX274873	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	882
AB467810	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	858
AB467809	SabinLike	healthy	Shedding of vaccine viruses with increased antigenic and geneticdivergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine 	858
JX274784	cVDPV	AFP	Multiple Independent Emergences of Type 2 Vaccine-DerivedPolioviruses during a Large Outbreak in northern Nigeria 	818
